Results: 208

Resecciones colorrectales segmentarias en pacientes con colitis ulcerosa y displasia o adenocarcinoma

Rev. cir. (Impr.); 72 (5), 2020
Resumen Introducción: El tratamiento estándar para los pacientes con colitis ulcerosa y displasia o adenocarcinoma de colon ha sido la proctocolectomía total, lo que conlleva una morbilidad y una reducción en la calidad de vida significativa. Materiales y Método: Se hace un análisis retrospectivo...

Serum expression of microRNA-16 in a cohort of Egyptian patients with ulcerative colitis and its correlation with disease extent and severity

Abstract Ulcerative colitis is one of the IBDs. Its etiology and pathogenesis remain undefined with an interaction between environmental, genetic and immunological factors is the most accepted explanation. Several recent studies have examined microRNA expression in the peripheral blood and tissues from I...

Epidemiological profile and hospitalization data of patients with inflammatory bowel disease

Abstract Objective: This study's objective was to understand the epidemiologic profile of the patients with inflammatory bowel disease in the state of Tocantins, Brazil. Methods: This is a descriptive study of secondary data, which was gathered by using the Informatics Department of the Brazilian Healt...

Microbiota, hábitos alimentarios y dieta en enfermedad inflamatoria intestinal

Rev. chil. nutr; 47 (5), 2020
RESUMEN La enfermedad de Crohn y Colitis Ulcerosa corresponden a Enfermedades Inflamatorias Intestinales (EII). En la actualidad aún no se ha establecido la cura de estas enfermedades; sin embargo, se han desarrollado diversas terapias dirigidas a disminuir la inflamación de la mucosa (5 aminosalicíli...

Hemophagocytic lymphohistiocytosis as a presentation of inflammatory bowel disease

Abstract Background: Hemophagocytic lymphohistiocytosis (HLH) is considered a medical emergency that should be recognized in patients with fever, splenomegaly, and progressive deterioration of the general condition. Laboratory findings include cytopenia, hypertriglyceridemia, hypofibrinogenemia, and hyp...

Tofacitinib en el tratamiento de la colitis ulcerosa: casos clínicos

Rev. méd. Chile; 148 (7), 2020
Biological therapy dramatically changed the management of Ulcerative Colitis (UC). However, a significant number of these patients fail to respond or have secondary loss of response to this strategy. In this clinical situation, the options include intensification of anti-TNF therapy, the use of a second ...

Colitis ulcerativa extensa severa presentación caso
Severe extensive ulcerative colitis. Case presentation

Rev. medica electron; 42 (3), 2020
RESUMEN La colitis ulcerativa es una enfermedad crónica recidivante del tracto gastrointestinal, que evoluciona por recaídas formando parte de las enfermedades inflamatorias intestinales (EII). Afecta la mucosa y submucosa del colon, caracterizada por un proceso ulcerativo y supurado de la mucosa. La d...

Nutritional status and consumption of inflammatory and anti-inflammatory foods by patients with inflammatory bowel diseases

ABSTRACT Objective Evaluation of nutritional status and consumption frequency of inflammatory and anti-inflammatory food by patients with inflammatory bowel diseases. Methods An observational study of the patients assisted by the interdisciplinary inflammatory bowel diseases ambulatory of UNIVALI-SC. T...

Patergia: implicações no tratamento das lesões do pioderma gangrenoso

Rev. enferm. UFPI; 9 (), 2020
Objetivo: relatar o tratamento tópico usado em um caso de Pioderma Gangrenoso em uma mulher de 45 anos que apresentou manifestações clínicas típicas e que obteve boa resposta ao desbridamento cirúrgico, apesar do potencial risco de patergia, bem como apresentar breve revisão da literatura sobre es...